An independent and privately held investment and wealth management firm, Glenmede was founded in 1956 to serve in perpetuity as the investment manager and trustee of the Pew family's charitable interestsThe Pew Trusts. Today our trust company provides highly customized investment, fiduciary and advisory services to high-net-worth individuals and families, endowments, foundations and institutional entities, representing more than $37 billion of assets under management. Headquartered in Philadelphia, Pennsylvania, the firm has offices in New York City, New York; Morristown and Princeton, New Jersey; Washington, DC; Cleveland, Ohio and Wilmington, Delaware. Terms of Use for Glenmede Social Properties: https://www.glenmede.com/files/glenmede-social-media-policy-5-31-18.pdf

Catalyzing Innovation in Pharma with Data-driven Digital Products. The idea of DataZymes germinated with the realization that Pharma Commercial teams had few alternatives to the antiquated and inefficient solutions offered by traditional consulting and technology companies. Already a laggard in analytical maturity, the Pharma industry had been facing challenges to adapt to a Big Data world. We saw that the products offered by technology companies were too rigid and generic to handle novel problems. The custom solutions offered by consulting organizations took too long to deploy and required many services to maintain and improve. We felt the need for a different approach to finding solutions and we knew it would take a different kind of company to build it. That’s why DataZymes. We’re focused on creating the world’s best user experience for working with data, one that empowers people to ask and answer complex questions without requiring them to master querying languages, statistical modeling, or the command line. To achieve this, we are building platforms for integrating, managing, and securing data on top of which we layer applications for fully interactive machine-driven, human-assisted analysis.